Gland Pharma consolidated net profit rises 9.79% in the March 2022 quarter

Sales rise 24.25% to Rs 1103.01 crore

Net profit of Gland Pharma rose 9.79% to Rs 285.90 crore in the quarter ended March 2022 as against Rs 260.41 crore during the previous quarter ended March 2021. Sales rose 24.25% to Rs 1103.01 crore in the quarter ended March 2022 as against Rs 887.75 crore during the previous quarter ended March 2021.

For the full year,net profit rose 21.54% to Rs 1211.66 crore in the year ended March 2022 as against Rs 996.96 crore during the previous year ended March 2021. Sales rose 27.08% to Rs 4400.71 crore in the year ended March 2022 as against Rs 3462.88 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales1103.01887.75 24 4400.713462.88 27 OPM %31.5836.91 -34.3237.61 - PBDT411.56373.87 10 1728.851433.59 21 PBT380.48348.94 9 1618.551334.81 21 NP285.90260.41 10 1211.66996.96 22

Powered by Capital Market - Live News